Erasmus School of Health Policy & Management
Associate professor | Health Technology Assessment (HTA)
- blommestein@eshpm.eur.nl
More information
Work
- Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Margreet G. Franken (2025) - Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model Opens external - European Journal of Cancer, 218 - doi: 10.1016/j.ejca.2024.115071Opens external - [link]Opens external
- Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot & Hedwig M. Blommestein (2025) - Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study Opens external - Clinical and Translational Radiation Oncology, 51 - doi: 10.1016/j.ctro.2025.100913Opens external - [link]Opens external
- Gabe S. Sonke, Annemiek van Ommen-Nijhof, , Noor Wortelboer, Vincent van der Noort, Astrid C.P. Swinkels, Hedwig M. Blommestein, Cristina Guerrero Paez, Linda Mol, Aart Beeker, Karin Beelen, Lisanne C. Hamming, Joan B. Heijns, Aafke H. Honkoop, Paul C. de Jong, Quirine C. van Rossum-Schornagel, Christa van Schaik-van de Mheen, Jolien Tol, Cathrien S. Tromp-van Driel, Suzan Vrijaldenhoven, A. Elise van Leeuwen-Stok, Inge R. Konings & Agnes Jager (2024) - Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer Opens external - Nature, 636 (8042), 474-480 - doi: 10.1038/s41586-024-08035-2Opens external - [link]Opens external
- M. R. Seefat, C. A.M. Stege, B. I. Lissenberg-Witte, M. D. Levin, G. J. Timmers, M. Hoogendoorn, P. F. Ypma, S. K. Klein, G. A. Velders, M. Westerman, L. Strobbe, N. Durdu-Rayman, M. A. Davidis-van Schoonhoven, R. J.W. van Kampen, A. C. Dijk, A. Koster, M. H. Silbermann, E. van der Spek, A. Beeker, Z. Erjavec, N. C.H.P. de Graauw, M. B.L. Leys, P. Sonneveld, N. W.C.J. van de Donk, K. Nasserinejad, H. M. Blommestein, D. G.J. Cucchi & S. Zweegman (2024) - Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial Opens external - European Journal of Cancer, 207 - doi: 10.1016/j.ejca.2024.114153Opens external - [link]Opens external
- Christine Bennink, Mirian Brink, Saskia F.A. Duijts, Hans Scheurer, Pieter Sonneveld & Hedwig M. Blommestein (2024) - Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands Opens external - Clinical Lymphoma, Myeloma and Leukemia, 24 (9), 604-610 - doi: 10.1016/j.clml.2024.04.004Opens external - [link]Opens external
- M. R. Seefat, D. G.J. Cucchi, K. Groen, M. L. Donker, K. G. van der Hem, M. Westerman, A. M. Gerrits, A. Beeker, N. W.C.J. van de Donk, H. M. Blommestein & S. Zweegman (2024) - Treatment sequences and drug costs from diagnosis to death in multiple myeloma Opens external - European Journal of Haematology, 112 (3), 360-366 - doi: 10.1111/ejh.14119Opens external - [link]Opens external
- H. R. Mortensen, P. Populaire, L. Hoffmann, D. S. Moeller, A. Appelt, P. Nafteux, C. T. Muijs, C. Grau, M. A. Hawkins, E. G.C. Troost, G. Defraene, R. Canters, C. S. Clarke, D. C. Weber, E. W. Korevaar, K. Haustermans, M. Nordsmark, Val Gebski, M. P. Achiam, Sheraz R. Markar, Ganesh Radhakrishna, Maaike Berbee, Daniele Scartoni, Ester Orlandi, Jerome Doyen, Vincent Gregoire, Gilles Crehange, Johannes Langendijk, Paula Lorgelly, Hedwig M. Blommestein, Camilla S. Byskov, Mai L. Ehmsen, Maria Fuglsang Jensen, Gloria Vilches Freixas, Rebecca Bütoft & (2024) - Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer Opens external - Radiotherapy and Oncology, 190 - doi: 10.1016/j.radonc.2023.109980Opens external - [link]Opens external
- Marianne Luyendijk, Agnes Jager, Sanne M. Buijs, Sabine Siesling, Carin A.Uyl de Groot & Hedwig M. Blommestein (2023) - Cost-Effectiveness Analysis of MammaPrint<sup>®</sup> to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer Opens external - PharmacoEconomics, 41 (8), 981-997 - doi: 10.1007/s40273-023-01277-4Opens external - [link]Opens external
- Brenda Leeneman, Hedwig M. Blommestein, Annemieke van Dongen-Leunis, Mattia Algeri, Willem E. Fibbe, Liesbeth Oosten, Carin A. Uyl-de Groot & Frederick W. Thielen (2023) - Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease Opens external - European Journal of Haematology, 111 (2), 240-246 - doi: 10.1111/ejh.13987Opens external - [link]Opens external
- Christine Bennink, Hans Westgeest, Daan Schoonen, Femke Boersen, Pieter Sonneveld, Jan Hazelzet, Hedwig Blommestein & Marjolein Van Der Klift (2023) - High Hospital-related Costs at the End-of-life in Patients With Multiple Myeloma: A Single-center Study Opens external - HemaSphere, 7 (6) - doi: 10.1097/HS9.0000000000000913Opens external - [link]Opens external
Health Technology AssessmentOpens external
- Year Level
- master, master, master
- Year
- 2024
- Course Code
- GW4546M
Health Technology Assessment (Eu-HEM)Opens external
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4585M
Master Thesis HEPLOpens external
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Master Thesis HEOpens external
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
Master HEPL-HE 2024-2025Opens external
- Year
- 2024
- Course Code
- GWMTTHEPL